Despite few reports to the contrary (37–39), growing evidence suggests that TIMP2 principally displays anti-tumor capabilities in a manner that is not limited to its role in MP inhibition (19, 20, 30, 40–42). This evidence concerns the gene TIMP2 and neoplasm.